 |
Mogamulizumab |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2016-10-14 00:00:00 |
| Sponsor | Kyowa Kirin Limited |
Related Access Program
| |
Mogamulizumab |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2016-10-14 00:00:00 |
| Sponsor | Kyowa Kirin Limited |